Synthesis and biological evaluation of novel taxoids designed for targeted delivery to tumors
- 6 December 2004
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (23) , 5885-5888
- https://doi.org/10.1016/j.bmcl.2004.09.025
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Poly(L-glutamic acid)-paclitaxel conjugate is a potent enhancer of tumor radiocurabilityInternational Journal of Radiation Oncology*Biology*Physics, 2003
- Synthesis and Biological Evaluation of Paclitaxel−C225 Conjugate as a Model for Targeted Drug Delivery1Bioconjugate Chemistry, 2003
- Tumor-Specific Novel Taxoid−Monoclonal Antibody ConjugatesJournal of Medicinal Chemistry, 2002
- Ligand-targeted therapeutics in anticancer therapyNature Reviews Cancer, 2002
- Improving the efficacy of antibody-based cancer therapiesNature Reviews Cancer, 2001
- Selective tumor sensitization to taxanes with the mAb-drug conjugate cBR96-doxorubicinInternational Journal of Cancer, 2001
- Monoclonal Antibodies in the Treatment of Malignancy: Basic Concepts and Recent DevelopmentsCancer Investigation, 2001
- The Taxane DiterpenoidsJournal of Natural Products, 1999
- Targeted delivery of chemotherapeutics: tumor-activated prodrug therapyAdvanced Drug Delivery Reviews, 1998
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975